Narrow search
Showing 1 - 10 of 41,759
Cover Image
Handbuch Pharma-Management
Lonsert, Michael (contributor);  … - 1995
Persistent link: https://www.econbiz.de/10000429566
Cover Image
Ausgestaltungsvarianten und ökonomische Konsequenzen einer 4. Hürde für die Erstattung von Arzneimitteln
Sundmacher, Torsten; Jasper, Jörg - In: Zeitschrift für Wirtschaftspolitik 55 (2006) 1, pp. 92-124
Persistent link: https://www.econbiz.de/10003308997
Cover Image
Innovation im Arzneimittelmarkt
Klauber, Jürgen (ed.); Bausch, Jürgen (contributor);  … - 2000
Persistent link: https://www.econbiz.de/10001486392
Cover Image
On the design of patents for new pharmaceuticals
Van Cayseele, Patrick - In: European journal of political economy 5 (1989) 1, pp. 49-61
Persistent link: https://www.econbiz.de/10001077156
Cover Image
Consumption Externalities and Diffusion in Pharmaceutical Markets : Antiulcer Drugs
Berndt, Ernst R. - 2000
We examine the role of consumption externalities in the demand for pharmaceuticals at both the brand level and over a therapeutic class of drugs. These effects emerge when use of a drug by others affects its value, and/or conveys information abut efficacy and safety to patients and physicians....
Persistent link: https://www.econbiz.de/10012470978
Cover Image
Consumption Externalities and Diffusion in Pharmaceutical Markets : Antiulcer Drugs
Berndt, Ernst R.; Pindyck, Robert S.; Azoulay, Pierre - 2021
We examine the role of consumption externalities in the demand for pharmaceuticals at both the brand level and over a therapeutic class of drugs. These effects emerge when use of a drug by others affects its value, and/or conveys information abut efficacy and safety to patients and physicians....
Persistent link: https://www.econbiz.de/10013211641
Cover Image
Consumption Externalities and Diffusion in Pharmaceutical Markets : Antiulcer Drugs
Berndt, Ernst R.; Pindyck, Robert S.; Azoulay, Pierre - 2012
We examine the role of consumption externalities in the demand for pharmaceuticals at both the brand level and over a therapeutic class of drugs. Externalities emerge when use of a drug by others affects its value, and/or conveys information about efficacy and safety to patients and physicians....
Persistent link: https://www.econbiz.de/10014078657
Cover Image
Early entrant protection in approval regulation : theory and evidence from FDA drug review
Carpenter, Daniel P.; Moffitt, Susan I.; Moore, Colin D.; … - In: The journal of law, economics, & organization 26 (2010) 3, pp. 515-545
Persistent link: https://www.econbiz.de/10008797710
Cover Image
Regulatory agency discretion among competing industries : inside the FDA
Olson, Mary K. - In: The journal of law, economics, & organization 11 (1995) 2, pp. 379-405
Persistent link: https://www.econbiz.de/10001193744